Skip to main content Accessibility help
  • Cited by 1
  • Print publication year: 2015
  • Online publication date: February 2015

2 - A woman with hypertension

Related content

Powered by UNSILO


1. Cooper WO, Hernandez-Diaz S, Arbogast PG et al. Major congenital malformations after first trimester exposure to ACE inhibitors. N Engl J Med 2006; 354: 2443–51.
2. Li DK, Yang C, Andrade S, Tavares V, Ferber JR. Maternal exposure to angiotensin converting enzyme inhibitors in the first trimester and risk of malformations in offspring: a retrospective cohort study. BMJ 2011; 343: d5931.
3. Walfisch A, Al-maawali A, Moretti ME, Nickel C, Koren G. Teratogenicity of angiotensin converting enzyme inhibitors or receptor blockers. J Obstet Gynecol 2011; 31: 465–72.
4. Abalos E, Duley L, Steyn DW, Henderson-Smart DJ. Antihypertensive drug therapy for mild to moderate hypertension during pregnancy. Cochrane Database Syst Rev 2007; (1): CD002252. DOI: 10.1002/14651858.CD002252.pub2
5. Magee LA, von Dadelszen P, Chan S et al. The Control of Hypertension In Pregnancy Study pilot trial. BJOGgyneco 2007; 114: 770, e13–20.
6. Duley L, Henderson-Smart DJ, Meher S, King JF. Antiplatelet agents for preventing pre-eclampsia and its complications. Cochrane Database Syst Rev 2007; (2): CD004659. DOI: 10.1002/14651858.CD004659.pub2